Aminolab, a Korean amino acid material manufacturer, gained international attention by participating in the ‘Victam 2024 Health & Nutrition Asia’ exhibition held in Bangkok, Thailand, from March 12 to 14. Following their successful presence at Vietnam's livestock fair in 2023, Aminolab showcased their proprietary immune-boosting feed additive, Aminofarm, highlighting their cutting-edge technology in transforming slaughter blood into valuable resources.

Slaughter blood is rich in high-quality proteins, iron, and various essential minerals. By employing eco-friendly enzymatic decomposition methods, it can be converted into peptides and free amino acids, making it a valuable substance for both humans and livestock. Aminolab’s proprietary feed additive, Aminofarm, stands out as it contains 90% protein made up of low-molecular peptides and over 20 types of free amino acids. Additionally, the inclusion of nucleotides, a component of breast milk, enhances livestock immunity, particularly in piglets.
 

Aminolab’s booth at the exhibition attracted significant attention, hosting buyers from Thailand, Spain, Vietnam, and 13 other countries. Through 24 business meetings, the company secured instant export consultations worth ,000, demonstrating the global appeal of their innovative products and solutions.

As a Korean amino acid material manufacturer, Aminolab takes pride in its in-house development of animal blood resource recycling technology. Their method is regarded as one of the most environmentally friendly and versatile technologies available today. The company's solutions are designed to reduce environmental burdens while maximizing the potential of slaughter blood as an eco-friendly resource.

Aminolab expressed their gratitude for the overwhelming interest in their products and technology at the event. They stated, “The Victam 2024 exhibition was a great opportunity to showcase our technology to a global audience. We remain committed to expanding our presence in international markets through sustainable and innovative solutions.”

The company, founded in 2013, specializes in producing high-value amino acid materials and holds 13 patents related to blood recycling. Aminolab’s mission is to continue leading advancements in eco-friendly resource utilization while contributing to a sustainable future.